Diseases, Conditions, Syndromes

Albumin improves bacterial peritonitis outcomes

(HealthDay)—For patients with spontaneous bacterial peritonitis (SBP), albumin infusion is associated with reduced renal impairment and decreased mortality, according to research published in the February issue of Clinical ...

Cardiology

Stopping aspirin therapy after GI bleed ups cardiovascular risk

(HealthDay)—Patients with cardiovascular disease who discontinue low-dose aspirin therapy after peptic ulcer bleeding have a seven-fold higher risk of death or acute cardiovascular event, according to research published ...

Other

Injecting botox into stomach does not promote weight loss

Despite conflicting data in support of the practice, some overweight Americans looking for an easy fix have turned to gastric botox injections to help them lose weight. This month in Clinical Gastroenterology and Hepatology, ...

Diseases, Conditions, Syndromes

About 10 percent of neoplastic polyps incompletely resected

(HealthDay)—About 10 percent of neoplastic polyps are incompletely resected, with considerable variation in the rate of incomplete resection between endoscopists, according to a study published in the January issue of Gastroenterology.

Oncology & Cancer

Genetic CRC risk likely mediated by differential adenoma risk

(HealthDay)—Much of the genetic risk for colorectal cancer (CRC) in the general population is mediated by differential adenoma risk, according to research published in the January issue of Gastroenterology.

Inflammatory disorders

'Good' bug may have a role in bowel disease

(Medical Xpress)—A bug thought to be one of the 'good bacteria' in our gut may actually have a role in the development of a bowel disorder that is on the rise in Scotland.

Diseases, Conditions, Syndromes

New drug might help treat irritable bowel syndrome

(HealthDay)—A new drug significantly reduces the abdominal pain and constipation characteristic of certain types of irritable bowel syndrome, according to two new studies.

Diseases, Conditions, Syndromes

Many patients keep using PPIs after negative GERD test

(HealthDay) -- Nearly half of patients continue to use proton pump inhibitors (PPIs) even after pH studies confirm that they do not have gastroesophageal reflux disease (GERD), and most do not recall being instructed to stop ...

page 8 from 38